Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
Colorcon
Dow
Express Scripts
Medtronic

Last Updated: January 25, 2022

DrugPatentWatch Database Preview

Litigation Details for Auxilium Pharmaceuticals Inc. v. Upsher-Smith Laboratories Inc. (D. Del. 2013)


Email this page to a colleague

« Back to Dashboard

Auxilium Pharmaceuticals Inc. v. Upsher-Smith Laboratories Inc. (D. Del. 2013)

Docket ⤷  Try it Free Date Filed 2013-01-27
Court District Court, D. Delaware Date Terminated 2013-12-29
Cause 28:1338 Patent Infringement Assigned To Sue Lewis Robinson
Jury Demand None Referred To
Parties UPSHER-SMITH LABORATORIES INC.
Patents 6,010,718; 6,319,913; 6,503,894; 7,214,381; 7,320,968; 7,608,605; 7,608,606; 7,608,607; 7,608,608; 7,608,609; 7,608,610; 7,935,690; 8,063,029; 8,178,518
Attorneys Andrew Colin Mayo
Link to Docket External link to docket
Small Molecule Drugs cited in Auxilium Pharmaceuticals Inc. v. Upsher-Smith Laboratories Inc.
The small molecule drugs covered by the patents cited in this case are ⤷  Try it Free , ⤷  Try it Free , ⤷  Try it Free , and ⤷  Try it Free .
Biologic Drugs cited in Auxilium Pharmaceuticals Inc. v. Upsher-Smith Laboratories Inc.
The biologic drug covered by the patents cited in this case is ⤷  Try it Free .

Details for Auxilium Pharmaceuticals Inc. v. Upsher-Smith Laboratories Inc. (D. Del. 2013)

Date Filed Document No. Description Snippet Link To Document
2013-01-27 1 infringement of U.S. Patent Nos. 7,320,968 (the “’968 Patent”); 7,608,605 (the “’605 Patent”); 7,608,606 (the…’968 Patent; the ’605 Patent; the ’606 Patent; the ’607 Patent; the ’608 Patent; the ’609 Patent; the…’968 Patent, the ’605 Patent, the ’606 Patent, the ’607 Patent, the ’608 Patent, the ’609 Patent, the…the ’610 Patent; the ’690 Patent; the ’029 Patent; and the ’518 Patent in the Orange Book—formally known…the ’610 Patent, the ’690 Patent, the ’029 Patent, and the ’518 Patent. COUNT I External link to document
2013-12-04 120 skin. ('968 patent, 3:17 -59) U.S. Pat. No. 6,503,894 (the '894 patent) describes straight…. and U.S. Pat. No. 6,503,894 to Dudley et al. The '919 patent describes a topical … disclosure of Dudley et al. (U.S. Patent No. 6,503,894- hereafter "Dudley et…the '518 patent, '605 patent, '606 patent, '607 patent, and '609 patent are similarly…'518 patent, 24:14-15; '605 patent, 23:12; '606 patent, 23:39; '607 patent, 23:39, 24 External link to document
2013-12-29 125 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,320,968 B2; 7,608,605 B2; 7,608,606… 30 December 2013 1:13-cv-00148 830 Patent None District Court, D. Delaware External link to document
2013-01-27 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,320,968 B2; 7,608,605 B2; 7,608,606… 30 December 2013 1:13-cv-00148 830 Patent None District Court, D. Delaware External link to document
2013-05-10 52 invention claimed in a 2003 patent, U.S. Patent No 6,503,894, the “Dudley patent.” (Taavola Decl. Ex. 41 …apply to two of the patents-in- suit, the ’608 Patent and the ’610 Patent. These patents are continuations…“’606 Patent”); 7,608,607 ( “’607 Patent”); 7,608,608 ( “’608 Patent”); 7,608,609 ( “’609 Patent”); 7,…610 Patent”); 7,935,690 ( “’690 Patent”); 8,063,029 (“’029 Patent”); and 8,178,518 ( “’518 Patent”). (… of the ’968 Patent. Five of these patents (the ’605, ’606, ’607, ’609, and ’518 Patents) claim either External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Medtronic
Johnson and Johnson
Dow
Moodys
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.